Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate‐to‐severe psoriasis through 5 years of treatment (SCULPTURE Extension Study).
Saved in:
| Title: | Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate‐to‐severe psoriasis through 5 years of treatment (SCULPTURE Extension Study). |
|---|---|
| Authors: | Bissonnette, R.1 rbissonnette@innovaderm.ca, Luger, T.2, Thaçi, D.3, Toth, D.4, Lacombe, A.5, Xia, S.6, Mazur, R.5, Patekar, M.5, Charef, P.5, Milutinovic, M.5, Leonardi, C.7, Mrowietz, U.8 |
| Source: | Journal of the European Academy of Dermatology & Venereology. Sep2018, Vol. 32 Issue 9, p1507-1514. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 131393521 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate‐to‐severe psoriasis through 5 years of treatment (SCULPTURE Extension Study). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Bissonnette%2C+R%2E%22">Bissonnette, R.</searchLink><relatesTo>1</relatesTo><i> rbissonnette@innovaderm.ca</i><br /><searchLink fieldCode="AR" term="%22Luger%2C+T%2E%22">Luger, T.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Thaçi%2C+D%2E%22">Thaçi, D.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Toth%2C+D%2E%22">Toth, D.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Lacombe%2C+A%2E%22">Lacombe, A.</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Xia%2C+S%2E%22">Xia, S.</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Mazur%2C+R%2E%22">Mazur, R.</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Patekar%2C+M%2E%22">Patekar, M.</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Charef%2C+P%2E%22">Charef, P.</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Milutinovic%2C+M%2E%22">Milutinovic, M.</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Leonardi%2C+C%2E%22">Leonardi, C.</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Mrowietz%2C+U%2E%22">Mrowietz, U.</searchLink><relatesTo>8</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Journal+of+the+European+Academy+of+Dermatology+%26+Venereology%22">Journal of the European Academy of Dermatology & Venereology</searchLink>. Sep2018, Vol. 32 Issue 9, p1507-1514. 8p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=131393521 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/jdv.14878 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 8 StartPage: 1507 Titles: – TitleFull: Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate‐to‐severe psoriasis through 5 years of treatment (SCULPTURE Extension Study). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bissonnette, R. – PersonEntity: Name: NameFull: Luger, T. – PersonEntity: Name: NameFull: Thaçi, D. – PersonEntity: Name: NameFull: Toth, D. – PersonEntity: Name: NameFull: Lacombe, A. – PersonEntity: Name: NameFull: Xia, S. – PersonEntity: Name: NameFull: Mazur, R. – PersonEntity: Name: NameFull: Patekar, M. – PersonEntity: Name: NameFull: Charef, P. – PersonEntity: Name: NameFull: Milutinovic, M. – PersonEntity: Name: NameFull: Leonardi, C. – PersonEntity: Name: NameFull: Mrowietz, U. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: Sep2018 Type: published Y: 2018 Identifiers: – Type: issn-print Value: 09269959 Numbering: – Type: volume Value: 32 – Type: issue Value: 9 Titles: – TitleFull: Journal of the European Academy of Dermatology & Venereology Type: main |
| ResultId | 1 |